Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sobhan Oncology is a prominent Iranian pharmaceutical company dedicated to the production of high-quality anti-cancer medicines. Founded in 2002 and based in the Industrial City of Rasht, it stands as one of the most sophisticated oncology manufacturing sites in the Middle East. The company's facility is designed to meet international Good Manufacturing Practice (GMP) standards, featuring dedicated lines for cytotoxic oral and injectable products. Sobhan Oncology offers a diverse portfolio of chemotherapy agents, targeted therapies, and supportive care medications. As a key member of the Barkat Pharmaceutical Group, the company focuses on enhancing patient access to essential oncology treatments through local production and technology transfer. Its operations encompass research and development, large-scale manufacturing, and distribution within domestic and regional markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sobhan Oncology.